Latta seeks opioid enforcement answers

Submitted information

WASHINGTON, D.C. — At an Energy and Commerce Subcommittee on Health hearing, U.S. Representative Bob Latta (R-Bowling Green) questioned an official from the Drug Enforcement Agency (DEA) about law enforcement efforts to combat the opioid epidemic and coordination between the agency and the Department of Health and Human Services (HHS).

The hearing, entitled “Combatting the Opioid Crisis: Helping Communities Balance Enforcement and Patient Safety,” focused on finding solutions to the epidemic that is prevalent in communities across the country. The hearing kicks off a push by the Energy and Commerce Committee to pass legislation addressing the opioid crisis in the coming months. Latta has introduced the INFO Act, legislation that would improve the collection and availability of data relating to opioids.

“The opioid epidemic has hit Ohio hard and overdoses across the state continue to rise,” said Latta. “Finding solutions needs to be a priority here in Congress, and that’s why it’s so important that the Energy and Commerce Committee is beginning a full-court press to get legislation to the President’s desk to curb the abuse of opioids, treat those that are addicted to drugs, and hold accountable those that bring illicit drugs into our communities.

“Today, we heard valuable testimony that will be essential as we try to improve coordination between federal agencies, state, and local governments, law enforcement, health care professionals, and advocates,” he added.

Latta led off his questions to DEA Deputy Assistant Attorney Susan Gibson from the agency’s Diversion Control Division by asking about DEA’s coordination with HHS and followed up by asking about what DEA is doing to stop the importation of fentanyl. Video of the questions and Gibson’s response is available here.